Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

Full description

Bibliographic Details
Main Authors: Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary, Nada Zaidan
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
oncolytic herpes simplex virus (oHSV)
virotherapy
immunotherapy
cancer
Online Access:https://www.mdpi.com/2073-4409/10/6/1541

Internet

https://www.mdpi.com/2073-4409/10/6/1541

Similar Items